The Playground

  • There is no "Pathological Institute" in Reutlingen. There's a hospital in Reutlingen that has a pathology lab. That's not the same thing. Not in name and not in function. But never mind that because the video wasn't filmed there either.


    None of three professors in the video works at that pathology lab anyway. Or any pathology lab for that matter. Because all three of them are retired. Two of them used to be pathologists at least. So there's that. The third is a former professor for electrical engineering.


    None of the three professors speak for anyone but themselves. The German Society for Pathology (DGP) released a statement that strongly condemned the video:

    • These are personal expressions of opinion and not the position of our specialist society.
      As has already been critically noted by others, the data presented is not scientifically sound.
      The DGP is not yet aware of any noticeable correlation of deaths in connection with the COVID-19 vaccination - although it cannot of course be ruled out that the vaccination can also cause complications.
      The Paul Ehrlich Institute is responsible for recording and evaluating such undesirable side effects.
    • The person who does almost all of the talking in the three-hour video is Arne Burkhardt. He is a familiar face in the small but obnoxious German antivaxx scene. He gained a certain level of notoriety earlier this year after publishing a paper that called masks "the devil in disguise".
    • Arne Burkhardt claims to have published over 150 scientific papers. He is presumably well-acquainted with the scientific method. So why didn't he publish a paper about his supposed COVID-19 findings? Why did he hold a press conference on YouTube instead? Does he expect his colleagues to peer review a video? It certainly seems as if he's trying to bypass the peer review process entirely. So it probably comes as no surprise that his colleagues describe his conclusions as "incomprehensible".

    YouTube has already removed the video btw.

    And how does all of that end up in an English-speaking sub like r/conspiracy? The press conference was held in German after all. Maybe there are already a lot of articles that debunk the video. But how would we know? They're most likely all in German. That's surprisingly convenient for the good folks of r/conspiracy who don't like their conspiracy theories debunked.

  • We live now in what is for many people a post-factual world. What matters is strongly and passionately articulated opinion. It does not matter the expertise of those who make it, the scientific credibility of the claims, or the fact that it is only 0.1% of the population who make such wild claims.


    Facebook algorithms ensure that they come up as daily fare for the 20% of the population who have shown they instinctively favour such views.


    Sad.

  • Ivermectin Delivered by A Novel Product


    Ivermectin Delivered by A Novel Product
    Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Joel S. Hirschhorn Moving beyond
    trialsitenews.com


    Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.


    Joel S. Hirschhorn


    Moving beyond words is a new vote of confidence in using ivermectin to fight COVID with an innovative injectable product.


    There is good reason to have hope for a new way to deliver IVM to millions of people to fight COVID variants. It offers a very sound alternative to vaccines.



    With all of the considerable controversy about using IVM for treating and preventing COVID, something has slipped the attention of its supporters and critics. A relatively small French company has spent the past year or more developing an injectable product of IVM for prophylactic use and have it last in the body for months.


    It has successfully completed a safety study for relatively high doses of IVM over long periods. The company tested IVM taken daily in oral form to simulate the continuous release of the active substance by a long-acting injectable. It found the results fully supportive of their injectable approach.


    If the company is able to get the commercial product into the market and, if needed, get regulatory approval, their product could compete against COVID vaccines and avoid the need for the new Pfizer and Merck antiviral treatment drugs.


    This product would circumvent the many problems people face in getting IVM pills, in terms of its scarcity and cost. But the new product would probably require a prescription and a doctor, nurse or pharmacist to administer it. And so, it might be relatively expensive, though likely cheaper than vaccines and new Big Pharma drugs.


    One can imagine that this innovative product could be just like annual flu vaccines in how it is administered to large numbers of people in a multitude of places, including medical offices, drug stores and supermarket pharmacies. And it would be wonderful if medical insurance covered it like it does for flu shots.


    Here is some more information about this venture: The company is MedinCell. It has received financial support from the French government. It was started some years ago with the help of the Bill and Melinda Gates Foundation, before the work on IVM.


    Safety addressed

    At its website, it is possible to download a March 2021 lengthy and detailed assessment and review of IVM focusing on its history of intense global use and safety. The title is Medical Safety of Ivermectin. Here are the conclusions:


    “Hundreds of millions of human subjects have been treated with ivermectin for curative or prophylactic purposes worldwide over the last 3 decades. The reference list of this report demonstrates that a large body of data is available, which allows for a detailed analysis of ivermectin medical safety. Undoubtedly, uncertainties remain regarding ivermectin pharmacological effects and mechanisms of action, but when removed, this is not anticipated to alter the main conclusions of this report in any significant way as they rely on an extensive and consistent body of medical publications. Taking into account all the above, the author of the present analysis of the available medical data concludes that the safety profile of ivermectin has so far been excellent in the majority of treated human patients so that ivermectin human toxicity cannot be claimed to be a serious cause for concern.”


    About product design

    The company is based on the use of what they call BEPO® technology in the form of a pre-filled syringe, ready-to-use, with 24-month stability at room temperature. It creates the formation of a small subcutaneous deposit, fully bioresorbable, at the time of injection. This material acts as a mini pump that releases IVM regularly until it disappears or absorbs completely.


    The core mechanism is the controlled and extended release of the active pharmaceutical ingredient, such as IVM. The company claims a significant reduction in the quantity of medication required as part of a chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for as long as several months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, of the fully bioresorbable medicine.


    Optimism by the company

    Here is an optimistic statement about the prophylactic strategy for using IVM in the pandemic:


    “Our hypotheses are being confirmed, says Christophe Douat, CEO of MedinCell: the pandemic continues, and vaccination may not be enough to stop it. The body of clinical data and scientific knowledge supporting the efficacy of ivermectin at a therapeutic dose against Covid-19, in particular as a prophylaxis, continues to grow. In this context, our treatment, based on a widely known molecule, which could be stored at room temperature and which aims to offer protection for several months after a simple injection against Covid-19 and its variants, could become a key tool of the anti-Covid arsenal. Our goal is still to have a product ready in 2022. “


    In addition to wide preventive use by the population, the product could also be administered to people identified as Covid-19 contact cases to protect them. Here is another potential benefit: Assume that some people may continue to get ill with late stage COVID infection, even with a regular dose of IVM and come down with lung and breathing problems. But research and clinical evidence shows that the anti-inflammatory property of IVM can treat such lung issues and prevent death. Having IVM in the body for months could either prevent or greatly mitigate such late-stage problems, the major cause of hospital COVID deaths now.


    Conclusions

    For those of us who have embraced the use of IVM as a prevention strategy, this novel product could be of tremendous global importance, especially as new COVID variants inevitably become a problem.


    Moreover, there is increasing recognition that repeated COVID vaccine booster shots are not justified because they can weaken immune systems and, inevitably, lose their effectiveness within short periods. It is good news that the limits of boosters are being recognized by some people and organizations. For example, Boosters “can be done once, or maybe twice, but it’s not something that we can think should be repeated constantly,” Marco Cavaleri, the European Medicines Agency head of biological health threats and vaccines strategy, said recently. “We need to think about how we can transition from the current pandemic setting to a more endemic setting.”


    And the World Health Organization just said: “a vaccination strategy based on repeated booster doses of the original vaccine composition is unlikely to be appropriate or sustainable.”


    Along this same line of thinking was this observation in a recent detailed analysis: “A plausible conclusion is that aggressive vaccination campaigns accelerate the pace at which an individual’s immune system reaches an ‘aged’ status due to exuberant generation of memory B cells in response to the artificial stimuli induced by repeated vaccination… An even more worrisome possibility is that these vaccines, both the mRNA vaccines and the DNA vector vaccines, may be a pathway to crippling disease sometime in the future.”


    The injectable IVM product should be seen as a potential alternative to vaccine shots not only because they are increasingly ineffective, but also because of their increasingly documented adverse health impacts and deaths. If COVID is to be seen as endemic, like the flu, then this new product merits serious support.


    The question to be followed is if and how Big Pharma takes actions to stymie the French company’s efforts to fully commercialize their IVM injectable product in many countries

  • Mass General Expert Predicts: No Boosters. Normal Life. We Can Move on From Covid


    Mass General Expert Predicts: No Boosters. Normal Life. We Can Move on From Covid
    By Mary Beth PfeifferThis article is part of a publishing collaboration between Rescue and Trial Site News. The outstanding reporting by Mary Beth
    trialsitenews.com


    By Mary Beth Pfeiffer


    This article is part of a publishing collaboration between Rescue and Trial Site News. The outstanding reporting by Mary Beth Pfeiffer will be simultaneously published in both outlets. Please subscribe to Rescue and Trial Site News for incisive pandemic reporting.



    The director of global diseases at the prestigious Massachusetts General Hospital made his hopeful diagnosis recently in a conference call to colleagues. Mass General (above left, facing the Charles River in Boston and backed by the city skyline) is the teaching hospital for Harvard Medical School that has been ranked the number one hospital in America by U.S. News & World Report and leads all hospitals in NIH-funded research. (Photo from Massgeneral.org)

    The director of global infectious diseases at Massachusetts General Hospital is predicting what was unthinkable less than a month ago: The end of the pandemic.


    Dr. Edward Ryan made stunning and encouraging comments on the Omicron variant that give hope for a return to normalcy. Among these: Omicron will make boosters unnecessary. The covid virus will join the ranks of the “common cold.” And the latest wave will enter “clean up mode” shortly.


    “We are fighting the last war with COVID and should be pivoting back to normal life,” the summary of Dr. Ryan’s comments states. “Spring/Summer will be really nice!”


    Dr. Ryan is professor of medicine at the Harvard Medical School and professor of immunology and infectious diseases at the Harvard T.H. Chan School of Public Health. He also directs the Tropical and Geographic Medicine Center

    and Travelers’ Advice and Immunization Center, which is supported by the U.S. Centers for Disease Control and Prevention.


    His comments come from an undated summary (see full text below) of a conference call with Ryan that was shared last weekend among doctors and provided to me.


    In response to a request for comment, Massachusetts General Hospital issued a statement acknowledging that Dr. Ryan’s remarks had been shared “from an individual’s personal notes.”


    “These notes lack context, details, and nuance,” the statement said, noting they fail to reflect “the role that vaccines play in mitigating severe disease or death,” or to note that at-risk people should “continue to take extra precautions.”


    Significantly, the statement did not take issue with the accuracy of the conference call summary, which I had forwarded to both Ryan and media officials. Ryan did not respond to requests for comment.


    Assessing the situation in the Boston region, Ryan said that close to 100 percent of cases were Omicron.


    “Delta is almost completely gone from New England,” the notes said, meaning, significantly, that a more deadly variant has been displaced by a far milder one.


    “This surge will peak [in New England] sometime between 1/10 and 1/21 and then begin a quick downhill journey of two to four weeks,” the summary of the call stated.


    Perhaps the most surprising, and potentially controversial, statement from the call notes pertained to Ryan’s take on boosters for Omicron.


    “We won’t need a booster for omicron because they wouldn’t be able to develop one before it’s completely gone and we’re all going to get it which will give us the immunity we need to get through it,” the summary states.


    The booster statement is particularly startling in view of the near-universal mainstream medical support for vaccinations and boosters, including for children as young as five years old.


    Ryan allayed fears of rising hospitalizations. “Most of them are secondary admissions,” the summary states, meaning people admitted for something else but who test positive for Omicron.


    SARS-CoV-2 will be transformed by Omicron, the comments suggest.


    “COVID will join the 4 other coronaviruses we deal with that cause the common cold, upper respiratory infections, RSV, etc.,” a reference to respiratory syncytial virus, which usually causes generally mild, respiratory disease.


    “Lots of good news!” the summary concludes.



    Dr. Edward Ryan, director of global infectious diseases at Massachusetts General Hospital in Boston, ranked the number three hospital in the world by Newsweek, told colleagues that he believes Omicron will soon reduce covid to the ranks of the common cold. (Photo from Massgeneral.org)

    Here is the full text from the notetaker’s conversation with Dr. Ryan:

    “Notes from a call earlier with Edward Ryan MD, Director of International Infectious Disease Service at Massachusetts General Hospital:


    1. Close to 100% of the positive cases in MA are Omicron. Delta is almost completely gone from New England.


    2. This surge will peak sometime between 1/10 and 1/21 and then begin a quick downhill journey of two to four weeks.


    3. We will end up with a 20-50% positivity rate.


    4. February will be clean up mode, March will begin to return to “normal”!


    5. Omicron lives in your nose and upper respiratory area which is what makes it so contagious. It isn’t able to bond with your lungs like the other variants.


    6. The increased hospitalizations should be taken with a grain of salt as most of them are secondary admissions (i.e. people coming in for surgery, broken bones, etc. who are tested for COVID).


    7. We won’t need a booster for omicron because they wouldn’t be able to develop one before it’s completely gone and we’re all going to get it which will give us the immunity we need to get through it.


    8. COVID will join the 4 other coronaviruses we deal with that cause the common cold, upper respiratory infections, RSV, etc. It will become a pediatric disease mainly affecting young children with no immunity.


    9. About 40% of those infected will be asymptomatic


    10. Rapid tests are 50-80% sensitive to those with symptoms, only 30-60% sensitive to those without symptoms.


    11. Contact tracing is worthless because we’re all going to get it and there’s no way we could keep up with it.


    12. We are fighting the last war with COVID and should be pivoting back to normal life, but society isn’t quite ready for it yet.


    13. There is no need to stay home from work or to be a hermit unless you’re immunocompromised or 85 or older, but he does recommend staying away from large gatherings for the next six weeks.


    14. Spring/Summer will be really nice!


    Lots of good news!!!”


    Here is the statement from Massachusetts General Hospital on Dr. Ryan’s comments:

    “We are aware of COVID-19 information circulating online evidently reflecting an individual’s personal notes from listening to a talk by Edward Ryan, MD, director of Global Infectious Diseases at MGH. These notes lack context, details, and nuance. For instance, the role that vaccines play in mitigating severe disease or death was not included, and individuals with comorbid conditions should continue to take extra precautions to minimize contracting COVID irrelevant of age.

  • I repeat what I wrote before, we are now in the phase of regained enthusiasm and shortly before a new development which will make the SKLep obsolete. My guess is, that the process of slowly winding back could take 6 to 12 months.

    The waves roll in, pause, then slip back into the sea. This is the way it has been for uncounted eons. Waves rolling in, pause, and the waves roll out. Just like your breath. That’s right. Breathe in, pause, and breathe out. Let the distractions slowly fade away. The waves roll in, pause, the waves roll out. Breathe slowly in, pause, calmly breathe out…


    Then, somewhere out in the ocean, a sound. A nearly subsonic rumble. The creatures of the sea feel it, and sense danger. There is nowhere to go in the open sea, however, so the denizens of the deep school together tighter and await the disturbance fretfully. Somewhere, far, but not too far away, the sea floor suddenly drops, and the sea above falls sharply with it. The sea pours in from every angle, racing to the center of the disturbance, meets, then rushes away in a proud ring to tell the seashore what has happened.


    It is coming. The sea shore felt the waters rush away to search out the disturbance, and now it feels the waters return. Not as a calm, gently tumbling wave slipping onto the sandy shore, but as a monstrous, destructive wall of water looking to scour the shore clean, and drag the detritus back into the depths.

  • S antibodies come from either the vaccine or the infection. (N would be infection only).

    I always said you miss most of your primary school math. So please stop your FUD and just repeat the calculation. Any 12 year old can do it. The only thing we must agree is that all vaccinated have S antibodies...Else the rate would even be higher....


    Clown!

  • Ryan allayed fears of rising hospitalizations. “Most of them are secondary admissions,” the summary states, meaning people admitted for something else but who test positive for Omicron.

    In RSA this was >80%. So great for vaccine terrorists to fudge once more the figures. Since day 1 world wide hospitalization figures have been fudged by 40..50% depending on county...


    So the CoV-19 hospital load was just about halve of the claimed one and hospitals have been invited to cheat by a benefit payment for treating CoV-19 patients....(remember the 50% false positive for PCR tests... ==> double cheating).

  • I don't thin it is possible for the UK NHS to do a lot of cheating, it is well equipped with whistleblowers.

    UK is the only country with a law to punish people for publishing medical fake information. In most other countries doctors are rewarded (bribed) for publishing fake information...


    In Switzerland/USA it has been confirmed that the fake factor was 40..50% depending on exact time where one does look at it.

  • Great news from India: Delhi already announced yesterday to be on top of the Omicron wave and the other IVR states do very well with no increase in cases counts since 4 days.

    Israel looks much worse as the 4th booster as usual causes many CoV-19 victims. During last few days most deaths have been among boostered and vaccinated.

  • Great news from India: Delhi already announced yesterday to be on top of the Omicron wave and the other IVR states do very well with no increase in cases counts since 4 days.

    Israel looks much worse as the 4th booster as usual causes many CoV-19 victims. During last few days most deaths have been among boostered and vaccinated.

    Fake news then…?



    From another source….


    COVID-19: Israel hits 48,000 cases, serious patients increase
    While the number of deaths in January remains limited, in the last seven days 27 died of COVID-19, a 93% increase compared to previous weeks.
    www.jpost.com


    “In addition, the number of serious patients also increased. As of Thursday morning, they stood at 287, which is 40 more than on Wednesday. At the same time, the figures of patients on ventilators only increased slightly– to 69 compared with 64 on Wednesday – while those on extracorporeal membrane oxygenation (ECMO) machines that are used for the most severe patients remained stable at 12.

    All patients on ECMO and 58% of those intubated were not vaccinated.”

  • How could the German elect this fascist as Health minister ?


    Lauterbach: „Omicron ersetzt Impfung nicht“


    Corona-Liveblog: Lauterbach: „Omicron ersetzt Impfung nicht“
    Ungeimpften in Österreich drohen bald Strafen von bis zu 3600 Euro +++ Querdenker schicken Drohschreiben an Schulen +++ Erster Omikron-Fall in Olympia-Stadt…
    www.faz.net


    Omicron cannot replace vaccination. Reality:: Omicron makes all experimental vaccines superfluous as the risk to die from Omicron is lower than the vaccine risks...

    Future reality:: Real vaccines will replace the fake vaccine for certain exposed people. Real vaccines cannot be based on the full spike protein and these will need several virus proteins to be prone to mutation escape.


    May be Lauterbach's friends still hope to conserve the share value of Biontec than for sure will go down further next few weeks/months as there is no big income source left over...

  • Why is Omicron harmless ??


    Even the most fat country in the world (USA) sees a very large overall decrease in deaths with Omicron.


    Start of winter wave 1 November had about 1100 death/day thanks to no treatment.

    Today close to peek Omicron 1800 deaths/day, but with 11x more cases.


    In addition the positive rate shows the real case number is at least 10x larger. So we have at least 50x less death/case in the worst country. Of course the are better places in USA too where there are far less than 100x lower deaths... Further you have to assume that at least 50% of the hospital deaths are with Omicron not from... In RSA this relation was > 80% with!


    So CFR now is below 0.01% in most places what is below any flu.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.